The iconic success of Viagra, developed by copyright, undeniably transformed the approach of erectile dysfunctionality, and ignited a massive boom in the pharmaceutical sector. However, now, investing in firms reliant on aging blockbuster drugs like Viagra presents a complex landscape. Copycat co